PATENT CLAIM ANALYSIS

Application Number: 16023205
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "142100"]

Abstract:
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Claim (Index 9):
A stable aqueous pharmaceutical composition comprising:\n a) adalimumab; b) histidine and citrate buffers; c) sorbitol; and d) a surfactant, wherein i) said buffer does not comprise a combination of citrate and phosphate; ii) the composition is free of mannitol and sodium chloride, and iii) the composition has a pH of about 5 to about 5.5.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15799851', '15729243', '15726165', '15726195', '14661899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8297801059844162
- 35 USC 102 Novelty (BERT): 0.6312800092018445
- Combined Prediction Score: 0.8099300963061591
- Mean Citation Score: 608.831288
- Max Citation Score: 621.2606
- Similarity Product: 550.0144392384886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test